Cargando…

593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study

BACKGROUND: The utility of surveillance bronchoscopy (SB) in asymptomatic lung transplant recipients (LTR) is controversial. Guidelines regarding the timing of SB and diagnostic testing varies across centers. Studies evaluating the role of microbiologic testing are lacking. Our transplant institute...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillon, William, Parraga Acosta, Tommy J, Failla, Andrew J, Corrales, Julio, Mayur, Ramesh, Alangaden, George J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644480/
http://dx.doi.org/10.1093/ofid/ofab466.791
_version_ 1784610095649259520
author Dillon, William
Parraga Acosta, Tommy J
Failla, Andrew J
Corrales, Julio
Mayur, Ramesh
Alangaden, George J
author_facet Dillon, William
Parraga Acosta, Tommy J
Failla, Andrew J
Corrales, Julio
Mayur, Ramesh
Alangaden, George J
author_sort Dillon, William
collection PubMed
description BACKGROUND: The utility of surveillance bronchoscopy (SB) in asymptomatic lung transplant recipients (LTR) is controversial. Guidelines regarding the timing of SB and diagnostic testing varies across centers. Studies evaluating the role of microbiologic testing are lacking. Our transplant institute currently performs SB at week 1, and months 1, 3, 6, 9, 12, and 24 post-transplant. We evaluated if routine microbiologic testing obtained during SB impacted clinical management. METHODS: This observational cohort study was performed at Henry Ford Hospital, Detroit, MI and included all LTR done from August 2014 to August 2019. Clinical and laboratory data was abstracted from the electronic medical record Pre/post-SB. Bronchoscopies performed for new or worsening respiratory symptoms, decline in forced expiratory volume at one second ≥10%, new radiographic abnormalities and follow up bronchoscopies to assess stents or recent acute rejection were excluded. Microbiologic tests assessed are shown in Table 2. Management change was defined as reduction in immunosuppression or prescription of antimicrobials. Rate of change in clinical management based on microbiologic test positivity was the primary outcome. Data were analyzed with descriptive statistics. RESULTS: 449 SB in 107 LTR were evaluated. Median age was 63 years, 68% were male. The average number of SB performed per patient was 4.2 (Table 1). The most common microbiologic tests performed were bacterial (435), mycobacterial (427), and fungal including Pneumocystis jirovecii (1022) (Table 2). The rate of test positivity and resultant change in management are shown in Table 3. The rate of test positivity was highest for bacterial (54%), fungal (27%) and viral tests (6%) with management changes in 12%, 2%, and 3% respectively. Table 1. Patient Demographics [Image: see text] Table 2. Rate of Microbiologic Testing per Surveillance Bronchoscopy [Image: see text] Table 3. Rate of Microbiologic Positivity and Management Change per Surveillance Bronchoscopy [Image: see text] CONCLUSION: This is the largest study to specifically evaluate the role of routine microbiologic tests during SB in LTR. Bacterial cultures may be appropriate due to higher rates of management changes. However, routine fungal, AFB, and viral studies are unnecessary due to low true positivity, and consequent low rate of management changes. This represents an important opportunity for diagnostic and antimicrobial stewardship. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-8644480
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86444802021-12-06 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study Dillon, William Parraga Acosta, Tommy J Failla, Andrew J Corrales, Julio Mayur, Ramesh Alangaden, George J Open Forum Infect Dis Poster Abstracts BACKGROUND: The utility of surveillance bronchoscopy (SB) in asymptomatic lung transplant recipients (LTR) is controversial. Guidelines regarding the timing of SB and diagnostic testing varies across centers. Studies evaluating the role of microbiologic testing are lacking. Our transplant institute currently performs SB at week 1, and months 1, 3, 6, 9, 12, and 24 post-transplant. We evaluated if routine microbiologic testing obtained during SB impacted clinical management. METHODS: This observational cohort study was performed at Henry Ford Hospital, Detroit, MI and included all LTR done from August 2014 to August 2019. Clinical and laboratory data was abstracted from the electronic medical record Pre/post-SB. Bronchoscopies performed for new or worsening respiratory symptoms, decline in forced expiratory volume at one second ≥10%, new radiographic abnormalities and follow up bronchoscopies to assess stents or recent acute rejection were excluded. Microbiologic tests assessed are shown in Table 2. Management change was defined as reduction in immunosuppression or prescription of antimicrobials. Rate of change in clinical management based on microbiologic test positivity was the primary outcome. Data were analyzed with descriptive statistics. RESULTS: 449 SB in 107 LTR were evaluated. Median age was 63 years, 68% were male. The average number of SB performed per patient was 4.2 (Table 1). The most common microbiologic tests performed were bacterial (435), mycobacterial (427), and fungal including Pneumocystis jirovecii (1022) (Table 2). The rate of test positivity and resultant change in management are shown in Table 3. The rate of test positivity was highest for bacterial (54%), fungal (27%) and viral tests (6%) with management changes in 12%, 2%, and 3% respectively. Table 1. Patient Demographics [Image: see text] Table 2. Rate of Microbiologic Testing per Surveillance Bronchoscopy [Image: see text] Table 3. Rate of Microbiologic Positivity and Management Change per Surveillance Bronchoscopy [Image: see text] CONCLUSION: This is the largest study to specifically evaluate the role of routine microbiologic tests during SB in LTR. Bacterial cultures may be appropriate due to higher rates of management changes. However, routine fungal, AFB, and viral studies are unnecessary due to low true positivity, and consequent low rate of management changes. This represents an important opportunity for diagnostic and antimicrobial stewardship. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2021-12-04 /pmc/articles/PMC8644480/ http://dx.doi.org/10.1093/ofid/ofab466.791 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Abstracts
Dillon, William
Parraga Acosta, Tommy J
Failla, Andrew J
Corrales, Julio
Mayur, Ramesh
Alangaden, George J
593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title_full 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title_fullStr 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title_full_unstemmed 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title_short 593. Utility of Microbiologic Testing Obtained via Bronchoalveolar Lavage on Asymptomatic Lung Transplant Recipients: A Quality Improvement Study
title_sort 593. utility of microbiologic testing obtained via bronchoalveolar lavage on asymptomatic lung transplant recipients: a quality improvement study
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644480/
http://dx.doi.org/10.1093/ofid/ofab466.791
work_keys_str_mv AT dillonwilliam 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy
AT parragaacostatommyj 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy
AT faillaandrewj 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy
AT corralesjulio 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy
AT mayurramesh 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy
AT alangadengeorgej 593utilityofmicrobiologictestingobtainedviabronchoalveolarlavageonasymptomaticlungtransplantrecipientsaqualityimprovementstudy